Zepp Health Q2 EPS $(0.15) Down From $(0.13) YoY, Sales $40.60M Down From $89.40M YoY
Portfolio Pulse from Benzinga Newsdesk
Zepp Health reported a Q2 EPS loss of $(0.15), a 15.38% decline from last year's $(0.13) loss. Sales also fell by 54.59% to $40.60M from $89.40M YoY.
August 22, 2024 | 7:35 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Zepp Health's Q2 results show a worsening financial position with EPS losses increasing to $(0.15) and sales dropping significantly by 54.59% YoY.
The reported increase in EPS losses and significant drop in sales indicate financial struggles, likely leading to negative investor sentiment and short-term stock price decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100